![David Evans](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Evans
Corporate Officer/Principal chez
SIRNAOMICS LTD.
Profil
David Mark Evans is the founder of Sirnaomics, Inc. (2007) as Head-Drug Discovery & Collaboration and Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd. (2008) as Chief Scientific Officer & Executive Director.
Dr. Evans is currently Head-Drug Discovery & Collaboration at Sirnaomics Ltd. since 2008.
Former positions include Senior Director at Dharmacon, Inc., Vice President-Operations at Emerald BioStructures, Inc. in 2012, and Head-Vitro Screening Group at Frederick National Laboratory For Cancer Research from 2013 to 2018.
Education includes an undergraduate degree from Imperial College London (1983) and a doctorate from Imperial College London (1988).
Postes actifs de David Evans
| Sociétés | Poste | Début |
|---|---|---|
| SIRNAOMICS LTD. | Corporate Officer/Principal | - |
Sirnaomics, Inc.
 Sirnaomics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel targeted therapeutics for critical human diseases | Fondateur | 01/01/2007 |
Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd.
 Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd. Pharmaceuticals: MajorHealth Technology Develops nucleic acid drugs | Fondateur | 10/03/2008 |
Anciens postes connus de David Evans
| Sociétés | Poste | Fin |
|---|---|---|
Frederick National Laboratory For Cancer Research
 Frederick National Laboratory For Cancer Research Aerospace & DefenseElectronic Technology Frederick National Laboratory for Cancer Research operates as a federally funded biomedical research institution dedicated to advancing understanding and treatment of cancer, AIDS, and infectious diseases. Frederick National Laboratory provides technical services such as HIV/SIV testing, HPV genotyping, antibody characterization, and nanomedicine studies, and offers training and educational modules to enhance research capacity. The company is based in Frederick. The laboratory offers specialized research programs and cores in areas such as basic science, cancer research technology, vaccine and immunity, molecular immunology, retroviral pathogenesis, bioinformatics, computational science, and clinical research. It integrates fundamental, translational, and clinical research with advanced technological capabilities including molecular diagnostics, nanotechnology characterization, cryo-electron microscopy, and multi-modality small animal imaging. The laboratory supports innovation through initiatives like the RAS Initiative and the Center for Innovation and Strategic Partnerships, fostering technology development, patents, and collaborations. Its bioinformatics directorate leverages artificial intelligence, machine learning, and advanced computing to analyze genomics, proteomics, and imaging data, supporting nationwide biomedical research efforts. The American company is ultimately controlled by the Government of the United States of America. | Corporate Officer/Principal | 01/04/2018 |
Emerald BioStructures, Inc.
 Emerald BioStructures, Inc. Miscellaneous Commercial ServicesCommercial Services Offers products and services in protein X-ray crystallography, specializing in the area of protein crystallization | Directeur des opérations | 01/12/2012 |
Dharmacon, Inc.
 Dharmacon, Inc. Miscellaneous Commercial ServicesCommercial Services Develops and commercializes new technology for RNA oligonucleotide synthesis | Directeur/Membre du Conseil | - |
Formation de David Evans
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
81
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Imperial College London
 Imperial College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Emerald BioStructures, Inc.
Emerald BioStructures, Inc. Miscellaneous Commercial ServicesCommercial Services Offers products and services in protein X-ray crystallography, specializing in the area of protein crystallization | Commercial Services |
Dharmacon, Inc.
Dharmacon, Inc. Miscellaneous Commercial ServicesCommercial Services Develops and commercializes new technology for RNA oligonucleotide synthesis | Commercial Services |
Sirnaomics, Inc.
Sirnaomics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel targeted therapeutics for critical human diseases | Health Technology |
Frederick National Laboratory For Cancer Research
Frederick National Laboratory For Cancer Research Aerospace & DefenseElectronic Technology Frederick National Laboratory for Cancer Research operates as a federally funded biomedical research institution dedicated to advancing understanding and treatment of cancer, AIDS, and infectious diseases. Frederick National Laboratory provides technical services such as HIV/SIV testing, HPV genotyping, antibody characterization, and nanomedicine studies, and offers training and educational modules to enhance research capacity. The company is based in Frederick. The laboratory offers specialized research programs and cores in areas such as basic science, cancer research technology, vaccine and immunity, molecular immunology, retroviral pathogenesis, bioinformatics, computational science, and clinical research. It integrates fundamental, translational, and clinical research with advanced technological capabilities including molecular diagnostics, nanotechnology characterization, cryo-electron microscopy, and multi-modality small animal imaging. The laboratory supports innovation through initiatives like the RAS Initiative and the Center for Innovation and Strategic Partnerships, fostering technology development, patents, and collaborations. Its bioinformatics directorate leverages artificial intelligence, machine learning, and advanced computing to analyze genomics, proteomics, and imaging data, supporting nationwide biomedical research efforts. The American company is ultimately controlled by the Government of the United States of America. | Electronic Technology |
Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd.
Sirnaomics Biopharmaceuticals (Suzhou) Co., Ltd. Pharmaceuticals: MajorHealth Technology Develops nucleic acid drugs | Health Technology |
Sirnaomics Ltd.
 Sirnaomics Ltd. BiotechnologyHealth Technology Develops therapeutics for treatment of cancer and fibrosis diseases | Health Technology |
